SCHEMBL13748372

SCHEMBL13748372

NC(=O)Cc1ccccc1CN1CCCC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
MPO P05164 2/20 0.46
CHRNA7 P36544 1/20 0.45
KDM4E B2RXH2 2/20 0.45
VEGFA P15692 1/20 0.45
EGLN1 Q9GZT9 1/20 0.45
POLB P06746 1/20 0.44
ACHE P22303 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
APOBEC3A P31941 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42
APP P05067 1/20 0.42
TSHR P16473 1/20 0.41
CYP2D6 P10635 1/20 0.41
OPRK1 P41145 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13747641 0.98 ALDH1A1 (0.53) ALDH1A1MEN1KMT2AMPOCHRNA7
SCHEMBL755778 0.84 KMT2A (0.55) ALDH1A1MEN1KMT2AMPOCHRNA7
SCHEMBL753109 0.83 KMT2A (0.57) ALDH1A1MEN1KMT2AMPOCHRNA7
SCHEMBL19364613 0.83 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AMPOCHRNA7
SCHEMBL890075 0.83 MEN1 (0.54) ALDH1A1MEN1KMT2AMPOCHRNA7
SCHEMBL890107 0.81 KMT2A (0.56) ALDH1A1MEN1KMT2AMPOCHRNA7
SCHEMBL19364663 0.81 ALDH1A1 (0.53) ALDH1A1MEN1KMT2AMPOCHRNA7
SCHEMBL11196594 0.81 ALDH1A1 (0.69) ALDH1A1MEN1KMT2AMPOCHRNA7
SCHEMBL10140834 0.80 KMT2A (0.51) ALDH1A1MEN1KMT2AMPOCHRNA7
SCHEMBL888667 0.80 MEN1 (0.51) ALDH1A1MEN1KMT2AMPOCHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009102325-A1 IMIDAZOLYL BIPHENYL IMIDAZOLES AS HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-20 WO disclosed
WO-2008021927-A2 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-02-21 WO disclosed